Adaptative designs and sites. Pierre Gervais Pierre Gervais President, Q&T Research, Sherbrooke President, AQRC.

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

Building A Clinical Trial Budget The Vanderbilt Way Lynda Lane, MS, RN Administrative Director, GCRC.
The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel Drug Research Unit Maastricht.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
Capturing and Reporting Adverse Events in Clinical Research
HIV Clinical Trials Janice Price, M.Ed, RN HIV Clinical Research Program Coordinator Swedish Medical Center Seattle, WA USA.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
Managing Sponsorship Research Services University of Oxford.
YALE MASTER SLIDE HERE Clinical Research Management – Is not just a handshake deal? Jamie Caldwell, MBA Director Office of Research Services for the Health.
The Role of Information Technology For A Private Medical Practice Noel Chua Rosalinda Raymundo.
| LUMIS International GmbH | Successful conduct of clinical trials to prove biosimilarity through defining a best fit outsourcing strategy Heike Schoen,
ABS Health, LLC 12466, E Washington Blvd, Whittier, CA – Phone
Donna W. Dorozinsky, RN, MSN, CCRC.  Understand that we are not alone in the challenges that we face in Phase I  Identify some possible solutions to.
Good Clinical Practice GCP
Healing Hands Clinical Research Services is a Site Management organization with broad spectrum of activities.
Federal Institute for Drugs and Medical Devices The BfArM is a Federal Institute within the portfolio of the Federal Ministry of Health 1 Quality of Bioequivalence.
Protocol Complexity as a Factor in Vendor Management Compliance Risk
ASH SPECIALIST PROGRAM REPORT Thomas D. Giles, MD, President of the ASH Specialist Program Inc.,
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Clinical Research Training
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Diabetes Clinical and Translational Research: Rewards and Challenges Ruth S. Weinstock MD PhD Medical Director, Joslin Diabetes Center and Clinical Research.
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
Copyright © CRF Box, Ltd. All rights reserved. 1 Introduction to Electronic Data Collection Methods; Improving Data Quality and Integrity in Epidemiological.
1 Nuts and Bolts of Safety Reporting The Role of the CRO Dr. Noa Lowenton Spier Pharma-Clinical S.A.G.
New Role Models for the EDC Study Team Training, workflow and service provision DTI Conference Centre 1 st November 2005 Emma Banks Datatrial Limited.
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
Experimental Cancer Medicine – the future of cancer care Rosie Davies (LECMC RP based at RLUH) Janet Davies (LECMC RP based at CCO)
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Integrating Services Research into CTN Clinical Trials: The Devil is in the Details Harold I Perl, PhD Center for the Clinical Trials Network National.
Department of Quality and Regulatory Affairs Barbara Ann Karmanos Cancer Center The Karmanos Cancer Center Regulatory Readiness (for Non Clinical Staff)
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
1 Module 7 Discharge Planning Managing the Transition from Inpatient to Outpatient Care Diabetes Special Interest Group Georgia Hospital Association.
Molecule-to-Market-Place Quality
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
ISPE Central Canada Chapter Annual Meeting September 28, 2006 Yvon R. Tessier Pharmaceutical contract manufacturing challenges.
Innovating out of the recession in the NHS Steve Barnett, Chief Executive NHS Confederation 28 th October 2009 Foundation Trust Network - Primary Care.
Identifying and recruiting patients for clinical trials in the future: a pharma perspective Rob Thwaites EC/EFPIA Workshop on ” Primary and secondary use.
Clinical Computing Secure, reliable technology that improves clinical workflow at the point of care.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
Providing brief addictions treatment in an emergency department: Experiences of University of New Mexico Hospital research interventionists in the SMART-ED.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
Working with HIT Systems
Enterprise Customer/ Field Services Overview of Client Integration Processes August 9, 2012.
0 International Medical Cluster (IMC), to be established in Moscow, creates a unique framework for developing healthcare business: –IMC activities are.
Jamie Hayes. Clinical Trial Patient ? Real Patient ?
Making Clinical Trials More Efficient Site Management Organization (SMO)
Understanding Epidemiology Introduction to Epidemiology and Epidemiological Concepts.
GCP (GOOD CLINICAL PRACTISE)
September 18, 2009 Prepared for DIA GCP QA SIAC teleconference 1 GCP QA for Russia and the Ukraine.
CLINICAL TRIALS.
TITIN ANDRI WIHASTUTI SCHOOL OF NURSING FACULTY OF MEDICINE
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
The Role and Responsibilities of the Clinical Research Coordinator
MAINTAINING THE INVESTIGATOR’S SITE FILE
The PRIME Study Dr. Komalkirti Apte
The Many Careers of Pharmacy
REGULATORY PROBLEMS IN CARING OUT PRE- AND POST- AUTHORISATION CLINICAL TRIALS Dr Penka Decheva GCP Inspector, BDA.
Within Trial Decisions: Unblinding and Termination
Jennifer S. Novia INFO 643 March 6, 2011
Pharmacovigilance in clinical trials
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Myeloma UK Clinical Trial Network (CTN)
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Sites in CEE A reliable place for clinical research?
Presentation transcript:

Adaptative designs and sites. Pierre Gervais Pierre Gervais President, Q&T Research, Sherbrooke President, AQRC

Discuss areas mostly affected with implementation of Adaptive Designs (AD) 1. Approach to the patients, 2. Remote data entry 3. Study material.

PeopleParticipantsNursesPhysicians SystemsProjectsWorkFinances Budget & Cash flow These changes are applied over an already rapidly changing environment What is changing ? Actual load of pressure on sites to make changes.

Nurses «Must have» qualities «Must have» qualities Caring personalityCaring personality Well integrated nursing and medical knowledgeWell integrated nursing and medical knowledge Organised and structured mind… but also flexibleOrganised and structured mind… but also flexible A «Make it Happen!» mentalityA «Make it Happen!» mentality A «Sixth Sense» for problemsA «Sixth Sense» for problems BilingualismBilingualism Understanding roles and responsibilitiesUnderstanding roles and responsibilities i.e. managing a study vs managing a site i.e. managing a study vs managing a site CRO / Sponsor / Site management / PI / AuditorCRO / Sponsor / Site management / PI / Auditor Computer literateComputer literate

Physicians Dedicated research time Dedicated research time Clinical research set up that is changing from amateur toprofessional Clinical research set up that is changing from amateur toprofessional Much more attractive Plan B Much more attractive Plan B More than 50% of physicians in the US will do only 1 trial. More than 50% of physicians in the US will do only 1 trial. Lack of US Investigators in ? Lack of US Investigators in ?

Projects Made on time Made on time Increasing globalisation Increasing globalisation Competitive pricing. Competitive pricing. One case in US = 1.0 $ One case in US = 1.0 $ In Canada = 0.87 $ In Canada = 0.87 $ In China = 0.18 $ In China = 0.18 $ In India = 0.27$ In India = 0.27$

Patients and population General population has a General population has a Negative opinion of drugsNegative opinion of drugs Perceived guinea pig activityPerceived guinea pig activity Lack of trustLack of trust Negative press in general Negative press in general Lack of knowledge of the population and the medical bodies Lack of knowledge of the population and the medical bodies

Erosion of patient trust in drugs and drug companies

Perception is often that: Drugs are commodities. Drugs are commodities. Drug companies are commodity providers. Drug companies are commodity providers.

Only in North America ? 4th Annual Forum on Patient Adherence, Compliance and Persistency November , 2007, Prague, Czech Republic II. Are Patients Being Scared off Their Medicines? II. Are Patients Being Scared off Their Medicines?

Erosion of trust in clinical research

There is a need to Develop a sufficient level of confidence and support from the community. Develop a sufficient level of confidence and support from the community. By investigative sitesBy investigative sites By pharmaceutical sponsorsBy pharmaceutical sponsors

AD / Approach to the patient Sites must be very careful when explaining the details of clinical research, experimentation, side effects, risks, etc to patients. Sites must be very careful when explaining the details of clinical research, experimentation, side effects, risks, etc to patients. Adaptative designs make our jobs even more challenging when we have to explain these complex designs and the risks of early treatment cessation are increased when designs are modified. Adaptative designs make our jobs even more challenging when we have to explain these complex designs and the risks of early treatment cessation are increased when designs are modified.

AD / Data entry Sponsors must analyse early and rapidly Sponsors must analyse early and rapidly Data to be entered into the system as it is generated by the site Data to be entered into the system as it is generated by the site New role is allocated to the sites but unfortunately very often without the necessarily equivalent resources New role is allocated to the sites but unfortunately very often without the necessarily equivalent resources data entry peopledata entry people or specific budget for RDEor specific budget for RDE

Actual management Protocols of increasing complexity Protocols of increasing complexity More visits More visits More procedures More procedures More documentation More documentation SOP, archive, study binder, …SOP, archive, study binder, … New roles, such as data entry (RDE) New roles, such as data entry (RDE) More hidden costs: More hidden costs: SAE reporting, Amendment (s…), data lock, data queries, deadlines, etcSAE reporting, Amendment (s…), data lock, data queries, deadlines, etc More reluctant patients More reluctant patients

AD and management All the above, plus All the above, plus Complex study medication packages Complex study medication packages Bulky laboratory boxes Bulky laboratory boxes Space is becoming an issue for centersSpace is becoming an issue for centers More reluctant patients More reluctant patients

Whats next ? Emergence of dedicated specialized in the conduct of trials Emergence of dedicated specialized in the conduct of trials An increasing challengeAn increasing challenge Part time investigative sites will not find their place with complex design and be left with much more simple trials, i.e. Phase IIIb and IV Part time investigative sites will not find their place with complex design and be left with much more simple trials, i.e. Phase IIIb and IV

Whats next ? Many physicians may very well simply return to their clinic, a reaction that will further increase the lack of investigative physicians. Many physicians may very well simply return to their clinic, a reaction that will further increase the lack of investigative physicians. More than 50% of US investigators will complete a 1572 only once. More than 50% of US investigators will complete a 1572 only once.

In conclusion While the use of AD is increasing, sites have to adapt their work strategies and the skills of the research staff. … and to carefully adapt with these changes while maintaining high standards for work ethics.